Dell has received CEO Cancer Gold Standard™ accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.
“CEO Cancer Gold Standard certification is further testament to Chairman and CEO, Michael Dell's leadership and to the company's well deserved reputation as an employer of choice.”
William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, nearly two million employees and family members are benefiting from the vision and leadership of employers who have chosen to become Gold Standard accredited.
"We are pleased to recognize Dell's efforts in the fight against cancer, starting with improving the health and wellness of the company's own employees," said Weldon. "CEO Cancer Gold Standard certification is further testament to Chairman and CEO, Michael Dell's leadership and to the company's well deserved reputation as an employer of choice."
The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials. Harvard Business Review recently highlighted the CEO Cancer Gold Standard, as an example of a high quality, signature program that can boost the overall effectiveness of a broad spectrum of workplace wellness initiatives.
AI-powered tool predicts gene activity in cancer cells from biopsy images